Getting a New Medicare Advantage Plan in 2026? 3 Things to Be on the Lookout For

Many seniors will face a new Medicare Advantage plan in 2026 — often because prior plans were discontinued or benefits and costs changed — and should promptly review differences in out‑of‑pocket costs (copays, deductibles and the plan’s maximum OOP), provider and pharmacy networks, and available telehealth services. Unlike original Medicare, Advantage plans have varied cost structures and network limits that can materially affect access to specialists and medication pricing, while expanding telehealth options may lower costs for some enrollees. Beneficiaries are urged to assess these items early in the year to avoid unexpected expenses and ensure continuity of care.

Analysis

Insurers expect material churn in Medicare Advantage coverage for 2026 as many beneficiaries switch because prior plans were discontinued or benefits and costs changed during fall open enrollment. The article emphasizes that MA plans vary materially from original Medicare in copays, deductibles and plan-specific maximum out-of-pocket (OOP) limits, so beneficiaries who anticipate significant medical needs must quantify those limits early in the year. Many retirees live on a mix of Social Security and modest savings, so shifts in cost-sharing or unexpected out-of-network bills can meaningfully affect household cash flow and medical-access decisions.

A central operational risk for enrollees is network configuration: MA plans commonly restrict care to in-network providers and pharmacies, and going out-of-network can produce steep charges; beneficiaries should verify whether key specialists and prescription sources are covered to avoid care disruption. Telehealth availability is expanding among MA plans and can lower access costs—virtual primary care, remote monitoring and mental-health services may have reduced or waived copays depending on plan rules. The practical takeaway is that plan design (cost-sharing, network breadth, telehealth benefits) will determine beneficiary outlays and service utilization, creating monitoring points for investors following payors, pharmacies and care-delivery platforms.

Key Decisions for Investors

• Monitor fall open-enrollment outcomes and plan discontinuation announcements closely, as switches driven by cost and network changes will affect insurer premium revenue and membership mix
• Favor insurers and managed-care platforms that advertise broad in-network provider and pharmacy access plus scalable telehealth offerings, since those features should retain members sensitive to access and OOP caps
• Track pharmacy network reconfigurations and potential shifts in prescription fill patterns because narrower networks can reallocate volume and impact retail pharmacy economics
• Hedge or re-evaluate positions in operators exposed to abrupt enrollment shifts or rising beneficiary cost-sharing; use plan-design trends (higher deductibles, narrower networks) as triggers to adjust exposure